Abbott Laboratories (ABT)

CapEx to Revenue

3.17%

Quarterly · Period ending:

ABT logo

ABT CapEx to Revenue

Latest reported3.17%
ABT Quarterly CapEx/Revenue (0.00% → 3.17%)
High-resolution chart · PNG

ABT capex to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Abbott Laboratories CapEx to Revenue — Quarterly
Period endingCapEx to Revenue
3.1684%
3.574%
6.0127%
4.3627%
4.5055%
4.6727%
6.561%
5.228%
5.1364%
3.9944%
7.3723%
5.521%
5.0812%
3.8986%
6.045%
4.4861%
3.3668%
2.6986%
5.354%
4.2185%
4.0399%
3.7969%
6.3452%
5.6026%
8.7609%
4.6596%
5.2201%
4.9653%
5.8654%
4.4459%
6.0142%
4.6238%
3.8367%
3.7212%
4.5461%
3.8512%
3.8421%
4.2936%
5.9816%
5.8846%
4.6315%
4.9744%
4.7803%
7.9806%
4.1779%
4.7989%
5.3585%
5.4271%
4.6478%
4.8627%
5.3697%
5.1491%
5.3327%
5.1035%
3.5628%
5.4307%
4.3348%
4.7936%
2.6474%
4.6042%
3.8785%
4.3337%
2.9227%
2.3641%
3.099%
3.1845%
2.7923%
4.2354%
3.5055%
3.7532%
3.3281%
4.2654%
5.0635%
4.9217%
5.9377%
6.078%
8.017%
6.2212%
5.0518%
6.3214%
6.8187%
5.7153%
5.1535%
4.8661%
5.4258%
6.2077%
6.33%
7.9442%
4.2144%
6.9704%
5.6136%
7.0476%
6.5594%
6.2202%
7.9825%
7.132%
6.3866%
7.7558%
8.1461%
9.8111%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.